# Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism

> **NCT00449007** · PHASE4 · TERMINATED · sponsor: **New York State Psychiatric Institute** · enrollment: 5 (actual)

## Conditions studied

- Depression
- Alcoholism
- Suicidal Behavior

## Interventions

- **DRUG:** fluoxetine
- **DRUG:** bupropion

## Key facts

- **NCT ID:** NCT00449007
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-02
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** recruitment of this population was not feasible
- **Last updated:** 2021-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00449007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00449007, "Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00449007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*